Protein Sciences, located in Meriden, CT, is a leading pharmaceutical company specializing in the development and production of influenza vaccines. Their portfolio includes Fluzone High-Dose Quadrivalent, Flublok Quadrivalent, and Fluzone Quadrivalent, which are all designed to provide active immunization against influenza A subtype viruses and type B viruses. These vaccines have been proven to be effective in preventing flu-related hospitalizations, particularly in older adults, and are approved for use in different age groups. Protein Sciences utilizes recombinant technology to manufacture their vaccines, ensuring high quality and safety standards.
With a focus on efficacy and safety, Protein Sciences conducts immunobridging and real-world evidence studies to support the effectiveness of their flu shots. Their higher-dose flu shots, Fluzone High-Dose Quadrivalent and Flublok Quadrivalent, have been shown to provide better protection against influenza compared to standard-dose vaccines in randomized controlled trials. These vaccines are available for order and are covered by Medicare and most commercial insurers. Protein Sciences is committed to protecting individuals from the hidden dangers of flu and offers resources for healthcare professionals and patients to promote awareness and prevention.
Generated from the website